Engineered small pox may kill liver cancer




As part of a multicenter clinical trial, researchers at University of California, San Diego School of Medicine are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma or liver cancer. Pexa-Vec is a genetically engineered virus that is used in the smallpox vaccine.

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/Z...

Martes, 9 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección